missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Itraconazole, Mikromol™
Description
Itraconazole
Spécification
Spécification
| Nom chimique ou matériau | Itraconazole |
| CAS | 84625-61-6 |
| Noms d’analytes ou de composants | Itraconazole |
| Conditions d’expédition | Température ambiante |
| Formule moléculaire | C35 H38 Cl2 N8 O4 |
| Certifications/Conformité | ISO 17034 |
| Synonyme | Itraconazole, 3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-, rel-, cis-Itraconazole, 4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-, rel-, Candistat, Canditral, Cladosal 100, Itrac, Itralek, Itrizole, Oriconazole, Orungal, R 51211, SUBA Itraconazole, Sempera, Spherazole CR, Spherazole IR, Sporal, Sporamelt, Sporanox, Sporanox IV, Sporonox, Traconal, Triasporin, rel-4-[4-[4-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one, Orungamin |
| Formule InChI | InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1 |
| SMILES | CCC(C)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(OC[C@H]5CO[C@@](Cn6cncn6)(O5)c7ccc(Cl)cc7Cl)cc4 |
| Nom IUPAC | 2-butan-2-il-4-[4-[4-[4-[[(2R,4S)-2-(2,4-diclorofenil)-2-(1,2,4-triazol-1-ilmetil)-1,3-dioxolan-4-il]metoxi]fenil]piperazin-1-il]fenil]-1,2,4-triazol-3-ona |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?